Limited neutralisation of the SARS-CoV-2 Omicron subvariants BA.1 and BA.2 by convalescent and vaccine serum and monoclonal antibodies.
- DOI
- 10.1016/j.ebiom.2022.104158
- Published
- 2022 Aug
- Container
- EBioMedicine
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.ebiom.2022.104158,
title = {Limited neutralisation of the SARS-CoV-2 Omicron subvariants BA.1 and BA.2 by convalescent and vaccine serum and monoclonal antibodies.},
author = {Wilhelm A and Widera M and Grikscheit K and Toptan T and Schenk B and Pallas C and Metzler M and Kohmer N and Hoehl S and Marschalek R and Herrmann E and Helfritz FA and Wolf T and Goetsch U and Ciesek S},
year = {2022},
journal = {EBioMedicine},
doi = {10.1016/j.ebiom.2022.104158},
url = {https://doi.org/10.1016/j.ebiom.2022.104158}
}RIS
TY - JOUR TI - Limited neutralisation of the SARS-CoV-2 Omicron subvariants BA.1 and BA.2 by convalescent and vaccine serum and monoclonal antibodies. AU - Wilhelm A AU - Widera M AU - Grikscheit K AU - Toptan T AU - Schenk B AU - Pallas C AU - Metzler M AU - Kohmer N AU - Hoehl S AU - Marschalek R AU - Herrmann E AU - Helfritz FA AU - Wolf T AU - Goetsch U AU - Ciesek S PY - 2022 JO - EBioMedicine DO - 10.1016/j.ebiom.2022.104158 UR - https://doi.org/10.1016/j.ebiom.2022.104158 ER -
APA
A, W., M, W., K, G., T, T., B, S., C, P., M, M., N, K., S, H., R, M., E, H., FA, H., T, W., U, G., & S, C. (2022). Limited neutralisation of the SARS-CoV-2 Omicron subvariants BA.1 and BA.2 by convalescent and vaccine serum and monoclonal antibodies.. EBioMedicine. https://doi.org/10.1016/j.ebiom.2022.104158
Source records
- pubmed · retrieved 2026-09-27T10:25:59.814Z